• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sanofi-Aventis S.A. ADR (NQ: SNY )

    56.05 -0.27 (-0.48%)
    Streaming Delayed Price Updated: 11:44 AM EDT, Aug 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 210,419
    Open 56.12
    Bid (Size) 56.03 (6)
    Ask (Size) 56.07 (7)
    Prev. Close 56.32
    Today's Range 56.05 - 56.38
    52wk Range 42.64 - 56.57
    Shares Outstanding 1,250,690,553
    Dividend Yield 3.40%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates
    State and local governments suing PBMs and drug companies over insulin prices have long benefited from the same rebate system they now criticize, leaving patients burdened by high costs and limited... 
    Via Benzinga
    Wall Street Predicts That This Stock Could Skyrocket by 65%: Time to Buy?
    Don't be too quick to jump on the Wall Street bandwagon. 
    Via The Motley Fool

    Performance

    YTD
    +12.10%
    +12.10%
    1 Month
    +7.60%
    +7.60%
    3 Month
    +16.92%
    +16.92%
    6 Month
    +16.26%
    +16.26%
    1 Year
    +4.26%
    +4.26%

    More News

    Read More
    ARS Pharmaceuticals 'Neffy Uniquely Positioned With Potential To Change Allergy Treatment Paradigm For First Time In 40 years:' Analyst
    Via Benzinga
    Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
    Via Investor's Business Daily
    NASDAQ:SNY is probably undervalued for the fundamentals it is displaying.
    Via Chartmill
    NASDAQ:SNY may be ready to breakout.
    Via Chartmill
    Florida Ruling Upholds GSK's Stance On Once Popular Heart Burn Drug Zantac Not Being Associated With Cancer Risk
    Via Benzinga
    3 Biotech Stocks to Buy on the Dip: August 2024
    Via InvestorPlace
    AnaptysBio Hits Five-Year High After Sanofi Takes A Stake In $100 Million Offering
    Via Investor's Business Daily
    Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
    Via MarketBeat
    Exposures COVID-19
    FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
    Via Benzinga
    Exposures Product Safety
    BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Reports on ‘Synergistic Effect’ of Lead Compound Plus GLP-1 in AD Treatment Model
    Via Investor Brand Network
    COVID-19 Vaccine Maker Novavax Trims Annual Outlook As Q2 Sales Take A Hit
    Via Benzinga
    Exposures COVID-19
    Sanofi's Approved Blood Cancer Drug Sarclisa Shows Improved Progression-Free Survival In Patients Eligible For Transplant
    Via Benzinga
    Alzheimer’s Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
    Via FinancialNewsMedia
    Alzheimer's Disease Diagnostics & Therapeutics Market Driven by Use of Biomarkers and Advancing R&D Activities
    From FN Media Group LLC
    Via GlobeNewswire
    Where Will Novavax Be in 5 Years?
    Via The Motley Fool
    Regeneron Pharmaceuticals' Q2 Earnings Exceed Estimates, Driven By Its Top-Selling Eczema And Eye Drugs
    Via Benzinga
    JPMorgan Just Cut Its Price Target on These 3 Stocks: July 31, 2024
    Via InvestorPlace
    JPMorgan Just Issued a Warning on Novavax (NVAX) Stock
    Via InvestorPlace
    Sanofi (SNY) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong Demand
    Via Benzinga
    25 Best Artificial Intelligence Stocks to Buy Right Now
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
    Via Benzinga
    Topics Economy
    Exposures Economy
    Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
    Via Benzinga
    Topics Government Stocks
    Exposures Political US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.